FDA Approves Poop-Based Pill to Treat Hardy Gut Infections
In a pivotal clinical trial, Vowst substantially reduced people's chances of developing recurrent C. difficile infections.
Source: gizmodo.com
Page 7 - Clostridioides Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clostridioides Difficile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clostridioides Difficile Today - Breaking & Trending Today
Fecal Microbiota Therapy Potentially Cost-effective at Preventing Recurrent CDI
The cost savings for health plans would increase if the therapy were used after the first recurrence of Clostridioides difficile infection (CDI).
Source: ajmc.com
Ferring Pharmaceuticals' 1st in Class C.diff Treatment, Rebyota, Experiences a Positive Early Launch Ahead of Potential Competition, According to Spherix Global Insights
/PRNewswire/ -- When the FDA approved Rebyota, a new class of Clostridioides Difficile (C.diff) treatment, Ferring Pharmaceuticals ushered in the first...
Source: prnewswire.com
Fecal Transplantation for Life-threatening Intestinal Infections
Early use of fecal microbiota transplantation (FMT) was found to cure Clostridioides difficile (C. difficile) infection.
Source: medindia.net
Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022
Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022.
Source: pressreleasepoint.com